KPTI vs REGN: Which Stock is Better?

Side-by-side comparison of Karyopharm Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

KPTI

Karyopharm Therapeutics Inc

$8.45

REGN

Regeneron Pharmaceuticals Inc

$755.51

Key Metrics Comparison

MetricKPTIREGNWinner
Market Cap$186.66M$78.92BREGN
P/E RatioN/A17.99REGN
EPS (TTM)$N/A$41.50REGN
Revenue Growth0.1%0.0%KPTI
Gross Margin9.9%44.6%REGN

Analyze KPTI

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KPTI or REGN a better investment?

Comparing KPTI and REGN: Karyopharm Therapeutics Inc has a market cap of $186.66M while Regeneron Pharmaceuticals Inc has $78.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KPTI and REGN?

KPTI (Karyopharm Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KPTI or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: KPTI or REGN?

KPTI has higher revenue growth at 0.1% vs 0.0% for REGN.

Which company is more profitable: KPTI or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 9.9% for KPTI.

Which is the larger company: KPTI or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.92B compared to $186.66M for KPTI.

Should I buy KPTI or REGN in 2026?

Both KPTI and REGN have investment merit. KPTI trades at $8.45 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KPTI and REGN stock?

Key differences: Market Cap ($186.66M vs $78.92B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.1% vs 0.0%), Gross Margin (9.9% vs 44.6%).

Popular Stock Comparisons